The dy2J/dy2J mouse model of merosin deficient congenital muscular dystrophy (MDC1A) is a useful model to study pharmacological intervention on mouse strength and mobility and muscle fibrosis. This evidence concerns the gene LAMA2 and congenital muscular dystrophy due to LMNA mutation.